Infezione occulta da HBV in pazienti con malattie oncoematologiche

Splenic marginal zone lymphoma with or without villous lymphocytes

The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the parameters predictive of shorter CSS were hemoglobin levels below 12 g/dL (P < .001), albumin levels below 3.5 g/dL (P = .001), International Prognostic Index (IPI) scores of 2 to 3 (P < .001), lactate dehydrogenase (LDH) levels above normal (P < .001), age older than 60 years (P = .01), platelet counts below 100,000/microL (P = .04), HbsAg-positivity (P = .01), and no splenectomy at diagnosis (P = .006). Values that maintained a negative influe…

Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients

Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Pre-empitive treatment with ciclofovir for cytomegalovirus antigenemia in autologous bone marrow recipient and CLL patients on therapy with alentuzumab

Presenting features and prognostic factors in Splenic Marginal Zone Lymphoma. A study on 145 patients.

Use of intrapleural bortezomib in myelomatous pleural effusion [1]